← Back to patent-cliff list
Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries )
Tier C — Watch / tradeNaltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries )
-
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Opioid receptors
Indications (approved)：Opioid dependence
Regional status
US
-
EU
-
China
Approved
2024-06-25
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries )?
Approved indications include: Opioid dependence.
When does the Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries ) patent expire?
No public expiry year is available for Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries ) yet; this page updates once verified.
How do I get a quote for Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries ) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27